Correlation Between Dyne Therapeutics and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Dyne Therapeutics and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyne Therapeutics and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyne Therapeutics and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on Dyne Therapeutics and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyne Therapeutics with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyne Therapeutics and Corbus Pharmaceuticals.
Diversification Opportunities for Dyne Therapeutics and Corbus Pharmaceuticals
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dyne and Corbus is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Dyne Therapeutics and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and Dyne Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyne Therapeutics are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of Dyne Therapeutics i.e., Dyne Therapeutics and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between Dyne Therapeutics and Corbus Pharmaceuticals
Considering the 90-day investment horizon Dyne Therapeutics is expected to generate 2.9 times less return on investment than Corbus Pharmaceuticals. But when comparing it to its historical volatility, Dyne Therapeutics is 2.82 times less risky than Corbus Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Corbus Pharmaceuticals Holding is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 370.00 in Corbus Pharmaceuticals Holding on August 27, 2024 and sell it today you would earn a total of 1,377 from holding Corbus Pharmaceuticals Holding or generate 372.16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Dyne Therapeutics vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| Dyne Therapeutics |
| Corbus Pharmaceuticals |
Dyne Therapeutics and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dyne Therapeutics and Corbus Pharmaceuticals
The main advantage of trading using opposite Dyne Therapeutics and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyne Therapeutics position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| Dyne Therapeutics vs. Stoke Therapeutics | Dyne Therapeutics vs. Pliant Therapeutics | Dyne Therapeutics vs. Cytokinetics | Dyne Therapeutics vs. Revolution Medicines |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |